Trial Outcomes & Findings for Opioid Analgesic Reduction Study (OARS) - Pilot (NCT NCT05283499)
NCT ID: NCT05283499
Last Updated: 2023-06-06
Results Overview
Average Pain (self reported by subject) rated on numeric rating scale (0=no pain, 10=worst pain imaginable)
COMPLETED
PHASE3
53 participants
1st day
2023-06-06
Participant Flow
Participant milestones
| Measure |
Opioid
Combination analgesic of hydrocodone 5mg/acetaminophen350 mg
OPIOID: Analgesic assignment
|
Non-Opioid
Combination analgesic of ibuprofen 400mgacademinophen 350mg
NON-OPIOID: Analgesic assignment
|
|---|---|---|
|
Overall Study
STARTED
|
26
|
27
|
|
Overall Study
COMPLETED
|
25
|
25
|
|
Overall Study
NOT COMPLETED
|
1
|
2
|
Reasons for withdrawal
| Measure |
Opioid
Combination analgesic of hydrocodone 5mg/acetaminophen350 mg
OPIOID: Analgesic assignment
|
Non-Opioid
Combination analgesic of ibuprofen 400mgacademinophen 350mg
NON-OPIOID: Analgesic assignment
|
|---|---|---|
|
Overall Study
Did not receive intervention
|
1
|
2
|
Baseline Characteristics
Opioid Analgesic Reduction Study (OARS) - Pilot
Baseline characteristics by cohort
| Measure |
Opioid
n=25 Participants
Combination analgesic of hydrocodone 5mg/acetaminophen350 mg
OPIOID: Analgesic assignment
|
Non-Opioid
n=25 Participants
Combination analgesic of ibuprofen 400mgacademinophen 350mg
NON-OPIOID: Analgesic assignment
|
Total
n=50 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Categorical
<=18 years
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Age, Categorical
Between 18 and 65 years
|
25 Participants
n=5 Participants
|
25 Participants
n=7 Participants
|
50 Participants
n=5 Participants
|
|
Age, Categorical
>=65 years
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Sex: Female, Male
Female
|
12 Participants
n=5 Participants
|
13 Participants
n=7 Participants
|
25 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
13 Participants
n=5 Participants
|
12 Participants
n=7 Participants
|
25 Participants
n=5 Participants
|
|
Ethnicity (NIH/OMB)
Hispanic or Latino
|
6 Participants
n=5 Participants
|
7 Participants
n=7 Participants
|
13 Participants
n=5 Participants
|
|
Ethnicity (NIH/OMB)
Not Hispanic or Latino
|
19 Participants
n=5 Participants
|
18 Participants
n=7 Participants
|
37 Participants
n=5 Participants
|
|
Ethnicity (NIH/OMB)
Unknown or Not Reported
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
American Indian or Alaska Native
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Asian
|
4 Participants
n=5 Participants
|
3 Participants
n=7 Participants
|
7 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
|
0 Participants
n=5 Participants
|
1 Participants
n=7 Participants
|
1 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Black or African American
|
10 Participants
n=5 Participants
|
7 Participants
n=7 Participants
|
17 Participants
n=5 Participants
|
|
Race (NIH/OMB)
White
|
3 Participants
n=5 Participants
|
11 Participants
n=7 Participants
|
14 Participants
n=5 Participants
|
|
Race (NIH/OMB)
More than one race
|
3 Participants
n=5 Participants
|
1 Participants
n=7 Participants
|
4 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Unknown or Not Reported
|
5 Participants
n=5 Participants
|
2 Participants
n=7 Participants
|
7 Participants
n=5 Participants
|
|
Region of Enrollment
United States
|
25 participants
n=5 Participants
|
25 participants
n=7 Participants
|
50 participants
n=5 Participants
|
PRIMARY outcome
Timeframe: 1st dayAverage Pain (self reported by subject) rated on numeric rating scale (0=no pain, 10=worst pain imaginable)
Outcome measures
| Measure |
Opioid
n=25 Participants
Combination analgesic of hydrocodone 5mg/acetaminophen350 mg
OPIOID: Analgesic assignment
|
Non-Opioid
n=25 Participants
Combination analgesic of ibuprofen 400mgacademinophen 350mg
NON-OPIOID: Analgesic assignment
|
|---|---|---|
|
Pain Level
|
5.67 score on a scale
Standard Error 0.59
|
4.09 score on a scale
Standard Error 0.59
|
PRIMARY outcome
Timeframe: Average for the 1st and 2nd dayAverage Pain (self reported by subject) rated on numeric rating scale (0=no pain, 10=worst pain
Outcome measures
| Measure |
Opioid
n=25 Participants
Combination analgesic of hydrocodone 5mg/acetaminophen350 mg
OPIOID: Analgesic assignment
|
Non-Opioid
n=25 Participants
Combination analgesic of ibuprofen 400mgacademinophen 350mg
NON-OPIOID: Analgesic assignment
|
|---|---|---|
|
Pain Level
|
5.10 score on a scale
Standard Error 0.58
|
3.57 score on a scale
Standard Error 0.58
|
PRIMARY outcome
Timeframe: Average for the first seven days post surgeryPain (self reported by subject) rated on numeric rating scale (0=no pain, 10=worst pain
Outcome measures
| Measure |
Opioid
n=25 Participants
Combination analgesic of hydrocodone 5mg/acetaminophen350 mg
OPIOID: Analgesic assignment
|
Non-Opioid
n=25 Participants
Combination analgesic of ibuprofen 400mgacademinophen 350mg
NON-OPIOID: Analgesic assignment
|
|---|---|---|
|
Pain Level
|
4.00 score on a scale
Standard Error 0.54
|
2.74 score on a scale
Standard Error 0.54
|
SECONDARY outcome
Timeframe: 1st nightQuality of overall sleep (self reported by subject) rated on numeric rating scale (0=best possible sleep possible, 10=worst possible sleep possible)
Outcome measures
| Measure |
Opioid
n=25 Participants
Combination analgesic of hydrocodone 5mg/acetaminophen350 mg
OPIOID: Analgesic assignment
|
Non-Opioid
n=25 Participants
Combination analgesic of ibuprofen 400mgacademinophen 350mg
NON-OPIOID: Analgesic assignment
|
|---|---|---|
|
Sleep Quality
|
5.45 score on a scale
Standard Error 0.69
|
3.76 score on a scale
Standard Error 0.70
|
SECONDARY outcome
Timeframe: Average for the 1st and 2nd nightQuality of overall sleep (self reported by subject) rated on numeric rating scale (0=best possible sleep possible, 10=worst possible sleep possible)
Outcome measures
| Measure |
Opioid
n=25 Participants
Combination analgesic of hydrocodone 5mg/acetaminophen350 mg
OPIOID: Analgesic assignment
|
Non-Opioid
n=25 Participants
Combination analgesic of ibuprofen 400mgacademinophen 350mg
NON-OPIOID: Analgesic assignment
|
|---|---|---|
|
Sleep Quality
|
5.25 score on a scale
Standard Error 0.64
|
3.44 score on a scale
Standard Error 0.65
|
SECONDARY outcome
Timeframe: Average for the 1st, 2nd and 3rd nightQuality of overall sleep (self reported by subject) rated on numeric rating scale (0=best possible sleep possible, 10=worst possible sleep possible)
Outcome measures
| Measure |
Opioid
n=25 Participants
Combination analgesic of hydrocodone 5mg/acetaminophen350 mg
OPIOID: Analgesic assignment
|
Non-Opioid
n=25 Participants
Combination analgesic of ibuprofen 400mgacademinophen 350mg
NON-OPIOID: Analgesic assignment
|
|---|---|---|
|
Sleep Quality
|
4.91 score on a scale
Standard Error 0.63
|
3.36 score on a scale
Standard Error 0.63
|
SECONDARY outcome
Timeframe: Average for the first seven nights post surgeryQuality of overall sleep (self reported by subject) rated on numeric rating scale (0=best possible sleep possible, 10=worst possible sleep possible)
Outcome measures
| Measure |
Opioid
n=25 Participants
Combination analgesic of hydrocodone 5mg/acetaminophen350 mg
OPIOID: Analgesic assignment
|
Non-Opioid
n=25 Participants
Combination analgesic of ibuprofen 400mgacademinophen 350mg
NON-OPIOID: Analgesic assignment
|
|---|---|---|
|
Sleep Quality
|
4.38 score on a scale
Standard Error 0.60
|
2.89 score on a scale
Standard Error 0.60
|
SECONDARY outcome
Timeframe: 1st dayImpact of pain on subject's ability to perform normal daily functions. The sum of six questions rated on a 5 point Likert Scale (1=not at all or never, 2=a little bit or rarely, 3=somewhat or sometimes, 4=quite a bit or often and 5=very much or always) The six questions are: 1) how much did pain interfere with your enjoyment of life, 2) how much did pain interfere with your ability to concentrate, 3) how much did pain interfere with your day to day activities, 4) how much did pain interfere with your enjoyment of recreational activities 5) how much did pain interfere with your tasks away form and home and 6) how often did pain keep you from socializing with others? Minimum = 6, Maximum = 30; lower is better and higher is worse outcome
Outcome measures
| Measure |
Opioid
n=25 Participants
Combination analgesic of hydrocodone 5mg/acetaminophen350 mg
OPIOID: Analgesic assignment
|
Non-Opioid
n=25 Participants
Combination analgesic of ibuprofen 400mgacademinophen 350mg
NON-OPIOID: Analgesic assignment
|
|---|---|---|
|
Pain Interference Scale (Patient Report Outcomes Measurement Information System - PROMIS 6b )
|
17.62 score on a scale
Standard Error 1.27
|
14.34 score on a scale
Standard Error 1.26
|
SECONDARY outcome
Timeframe: Average for the 1st and 2nd dayImpact of pain on subject's ability to perform normal daily functions. The sum of six questions rated on a 5 point Likert Scale (1=not at all or never, 2=a little bit or rarely, 3=somewhat or sometimes, 4=quite a bit or often and 5=very much or always) The six questions are: 1) how much did pain interfere with your enjoyment of life, 2) how much did pain interfere with your ability to concentrate, 3) how much did pain interfere with your day to day activities, 4) how much did pain interfere with your enjoyment of recreational activities 5) how much did pain interfere with your tasks away form and home and 6) how often did pain keep you from socializing with others? Minimum = 6, Maximum = 30; lower is better and higher is worse outcome
Outcome measures
| Measure |
Opioid
n=25 Participants
Combination analgesic of hydrocodone 5mg/acetaminophen350 mg
OPIOID: Analgesic assignment
|
Non-Opioid
n=25 Participants
Combination analgesic of ibuprofen 400mgacademinophen 350mg
NON-OPIOID: Analgesic assignment
|
|---|---|---|
|
Pain Interference Scale (Patient Report Outcomes Measurement Information System - PROMIS 6b )
|
16.21 score on a scale
Standard Error 1.18
|
12.91 score on a scale
Standard Error 1.19
|
SECONDARY outcome
Timeframe: Average for the 1st, 2nd and 3rd dayImpact of pain on subject's ability to perform normal daily functions. The sum of six questions rated on a 5 point Likert Scale (1=not at all or never, 2=a little bit or rarely, 3=somewhat or sometimes, 4=quite a bit or often and 5=very much or always) The six questions are: 1) how much did pain interfere with your enjoyment of life, 2) how much did pain interfere with your ability to concentrate, 3) how much did pain interfere with your day to day activities, 4) how much did pain interfere with your enjoyment of recreational activities 5) how much did pain interfere with your tasks away form and home and 6) how often did pain keep you from socializing with others? Minimum = 6, Maximum = 30; lower is better and higher is worse outcome
Outcome measures
| Measure |
Opioid
n=25 Participants
Combination analgesic of hydrocodone 5mg/acetaminophen350 mg
OPIOID: Analgesic assignment
|
Non-Opioid
n=25 Participants
Combination analgesic of ibuprofen 400mgacademinophen 350mg
NON-OPIOID: Analgesic assignment
|
|---|---|---|
|
Pain Interference Scale (Patient Report Outcomes Measurement Information System - PROMIS 6b )
|
15.50 score on a scale
Standard Error 1.15
|
12.19 score on a scale
Standard Error 1.16
|
SECONDARY outcome
Timeframe: Average for the first seven days post surgeryImpact of pain on subject's ability to perform normal daily functions. The sum of six questions rated on a 5 point Likert Scale (1=not at all or never, 2=a little bit or rarely, 3=somewhat or sometimes, 4=quite a bit or often and 5=very much or always) The six questions are: 1) how much did pain interfere with your enjoyment of life, 2) how much did pain interfere with your ability to concentrate, 3) how much did pain interfere with your day to day activities, 4) how much did pain interfere with your enjoyment of recreational activities 5) how much did pain interfere with your tasks away form and home and 6) how often did pain keep you from socializing with others? Minimum = 6, Maximum = 30; lower is better and higher is worse outcome
Outcome measures
| Measure |
Opioid
n=25 Participants
Combination analgesic of hydrocodone 5mg/acetaminophen350 mg
OPIOID: Analgesic assignment
|
Non-Opioid
n=25 Participants
Combination analgesic of ibuprofen 400mgacademinophen 350mg
NON-OPIOID: Analgesic assignment
|
|---|---|---|
|
Pain Interference Scale (Patient Report Outcomes Measurement Information System - PROMIS 6b )
|
13.74 score on a scale
Standard Error 1.12
|
11.01 score on a scale
Standard Error 1.13
|
SECONDARY outcome
Timeframe: Average for the first seven days post surgerySubject's rating of overall satisfaction with the analgesic provided after surgery on a 5 point Likert Scale (1=very satisfied, 2=satisfied, 3=neither satisfied or dissatisfied, 4=dissatisfied, 5=very dissatisfied)
Outcome measures
| Measure |
Opioid
n=25 Participants
Combination analgesic of hydrocodone 5mg/acetaminophen350 mg
OPIOID: Analgesic assignment
|
Non-Opioid
n=25 Participants
Combination analgesic of ibuprofen 400mgacademinophen 350mg
NON-OPIOID: Analgesic assignment
|
|---|---|---|
|
Overall Satisfaction
|
2.1 score on a scale
Standard Deviation 1.4
|
1.7 score on a scale
Standard Deviation 0.89
|
Adverse Events
OPIOID
NON-OPIOID
Serious adverse events
Adverse event data not reported
Other adverse events
| Measure |
OPIOID
n=25 participants at risk
Received hydrocodone/acetaminophen
|
NON-OPIOID
n=25 participants at risk
Received ibuprofen/acetaminophen
|
|---|---|---|
|
Gastrointestinal disorders
Constipation
|
4.0%
1/25 • Number of events 1 • Post-operative Period -- 9 Days +/- 5 days from surgery
Adverse event is defined as an event which required a unexpected office visit or visit to an emergency room and could be related to study intervention
|
0.00%
0/25 • Post-operative Period -- 9 Days +/- 5 days from surgery
Adverse event is defined as an event which required a unexpected office visit or visit to an emergency room and could be related to study intervention
|
Additional Information
Cecile A. Feldman
Rutgers University School of Dental Medicine
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place